Accommodating protein flexibility for structure-based drug design.
By Jung-Hsin Lin. 2011
68 citations recorded by the source corpus.
Subfields: Biotechnology, Computational Theory and Mathematics, Molecular Biology, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Glaucius Oliva
- L. Ferreira
- Ricardo N Dos Santos
- Adriano Defini Andricopulo
- António J. M. Ribeiro
- Rui P. P. Neves
- Pedro Alexandrino Fernandes
- Silvia A. Martins
In Molecular Biology
- Glaucius Oliva
- L. Ferreira
- Ricardo N Dos Santos
- Adriano Defini Andricopulo
- António J. M. Ribeiro
- Rui P. P. Neves
- Pedro Alexandrino Fernandes
- Silvia A. Martins
In Computational Chemistry & Drug Discovery
- António J. M. Ribeiro
- Rui P. P. Neves
- Pedro Alexandrino Fernandes
- Silvia A. Martins
- Maria João Ramos
- Glaucius Oliva
- João T. S. Coimbra
- Sérgio Filipe Sousa
Citations in the corpus
- Molecular Docking and Structure-Based Drug Design Strategies (2015, background): “Enzymes and receptors can undergo conformational changes during the molecular recognition process [97].”
- Protein-ligand docking in the new millennium--a retrospective of 10 years in the field. (2013, background): “However, even though most currently available docking methods already treat ligands as flexible, the inclusion of protein flexibility is still a challenging task, remaining one of the most important topics in development within the field of protein ligand docking [60-69].”